Safety and Efficacy of A-101 Hydrogen Peroxide Topical Solution in Adults With Seborrheic Keratosis: Results From the Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study

SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.1.supp.118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Society for Cutaneous Medicine

Related search

Safety and Efficacy of Hydrogen Peroxide Topical Solution, 40% (W/W) in Patients With Seborrheic Keratoses: Results From Two Identical, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (A-101-Sebk-301/302)

Journal of the American Academy of Dermatology
Dermatology
2018English

Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Protocol of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (NICOFA)

Neurological Research and Practice
2019English

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

SKIN The Journal of Cutaneous Medicine
2019English

Efficacy, Safety, and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: A Randomized, Double-Blind Phase 3 Study, MEASURE 3

Arthritis Research & Therapy
2017English

A Topical Microemulsion for the Prevention of Allergic Rhinitis Symptoms: Results of a Randomized, Controlled, Double-Blind, Parallel Group, Multicentre, Multinational Clinical Trial (Nares Study)

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Confirmatory Phase 2 Study

Clinical and Experimental Nephrology
PhysiologyNephrology
2019English

Long-Term Efficacy and Safety of Brodalumab in the Treatment of Psoriasis: 120-Week Results From the Randomized, Double-Blind, Placebo- And Active Comparator–controlled Phase 3 AMAGINE-2 Trial

Journal of the American Academy of Dermatology
Dermatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy